SCHEMBL3663510

SCHEMBL3663510

CCCCOC(=O)N1CCC(c2cc(C(=O)OCC)c(N)s2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 8/20 0.46
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 3/20 0.46
TSHR P16473 2/20 0.46
HTT P42858 1/20 0.46
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALOX15 P16050 2/20 0.41
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 2/20 0.41
BRD4 O60885 2/20 0.39
REV1 Q9UBZ9 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718737 0.84 ALDH1A1 (0.52) GAAALDH1A1HSD17B10TSHRHTT
SCHEMBL13160409 0.84 GAA (0.46) GAAALDH1A1HSD17B10TSHRHTT
SCHEMBL3663286 0.82 SMN1; SMN2 (0.54) GAAALDH1A1HSD17B10TSHRHTT
SCHEMBL3662214 0.78 GAA (0.57) GAAALDH1A1HSD17B10TSHRMAPK1
SCHEMBL3663944 0.76 GAA (0.58) GAAALDH1A1HSD17B10TSHRHTT
SCHEMBL3662027 0.74 ADORA1 (0.46) GAAALDH1A1HSD17B10MAPK1SMN1; SMN2
SCHEMBL30376364 0.72 LMNA (0.49) GAAALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL5441982 0.71 EED (0.50) ALDH1A1HTTMAPK1MAPTRAB9A
SCHEMBL4617667 0.71 LMNA (0.41) GAAALDH1A1HTTMAPK1SMN1; SMN2
SCHEMBL2453353 0.70 SMN1; SMN2 (0.42) GAAALDH1A1HSD17B10TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362008-B2 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors THE UNIVERSITY OF EDINBURGH (GB) 2013-01-29 US disclosed
US-20100267696-A1 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors THE UNIVERSITY OF EDINBURGH 2010-10-21 US disclosed
EP-2229374-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS THE UNIVERSITY OF EDINBURGH (GB) 2010-09-22 EP disclosed
WO-2009074789-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS THE UNIVERSITY OF EDINBURGH (GB) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267696-A1 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors HSD11B1, HSD11B2, HSD17B1 GAA 959/4885ALDH1A1 285/4885HSD17B10 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.